ClinicalTrials.Veeva

Menu

Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.

B

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Status and phase

Enrolling
Phase 2

Conditions

Acne Vulgaris

Treatments

Drug: Metformin and doxycycline

Study type

Interventional

Funder types

Other

Identifiers

NCT06252194
BSMMU/2022/11379

Details and patient eligibility

About

The goal of this clinical trial is to compare the effect of doxycycline and metformin in treatment of acne vulgaris patients. The main question is aimed to answer is whether metformin is more effective than doxycycline in treatment of acne vulgaris patient or not.

Patients will be asked to take doxycycline along with tropical treatment in one group and metformin along with tropical treatment in another group.

Researcher will compare the clinical improvement in two groups.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Newly diagnosed moderate and severe AV patients diagnosed by a dermatologist

Exclusion criteria

  • Patients receiving topical retinoids within last two months
  • Pregnancy and lactation
  • History of corticosteroids intake
  • Suffering from malignancy or any cosmetic induced acne

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

120 participants in 2 patient groups

Group A
Experimental group
Description:
Metformin 500 mg twice daily along with topical retinoids for 12 weeks
Treatment:
Drug: Metformin and doxycycline
Group B
Active Comparator group
Description:
Doxycycline 100 mg twice daily along with topical retinoids for 12 weeks
Treatment:
Drug: Metformin and doxycycline

Trial contacts and locations

1

Loading...

Central trial contact

Muhammad Marnush, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems